Reproductive factors and risk of biliary tract cancer in a population-based study

Acta Oncologica

Volumn 54, Issue 8, 2015, Pages 1152-1158

  Kilander, Carl ^a   Mattsson, Fredrik ^a   Lu, Yunxia ^a   Ljung, Rickard ^a   Lagergren, Jesper ^a,b   Sadr Azodi, Omid ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SWEDISH CITIZEN; VATER PAPILLA; VATER PAPILLA CARCINOMA; ADENOCARCINOMA; BILIARY TRACT NEOPLASMS; CASE CONTROL STUDY; MIDDLE AGED; ODDS RATIO; REGISTER; REPRODUCTIVE HISTORY; SWEDEN; YOUNG ADULT;

ADENOCARCINOMA; ADULT; BILIARY TRACT NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; REPRODUCTIVE HISTORY; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84940525197     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2015.1016627     Document Type: Article

References (47)

1. Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malago M. Review article: Surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther 2011;34:1063-78.
2. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-76.
3. Nordenstedt H, Mattsson F, El-Serag H, Lagergren J. Gallstones and cholecystectomy in relation to risk of intra-and extrahepatic cholangiocarcinoma. Br J Cancer 2012; 106:1011-5.
4. Karlsen TH, Schrumpf E, Boberg KM. Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2010;24:655-66.
5. Schlesinger S, Aleksandrova K, Pischon T, Jenab M, Fedirko V, Trepo E, et al. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol 2013;24:2449-55.
6. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991;48:323-8.
7. Cancer Statistics Database. National Board of Health and Welfare. [cited 2014 Nov 10]. http://www.socialstyrelsen.se.
8. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer 2006;118:1591-602.
9. Eslick GD. Epidemiology of gallbladder cancer. Gastroen- terol Clin North Am 2010;39:307-30, ix.
10. Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: Demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 2009;100:598-605.
11. Tominaga S, Kuroishi T. Biliary tract cancer. Cancer Surv 1994;19-20:125-37.
12. Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, et al. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control 1995;6:217-24.
13. Cunningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Wenstrom KD, Hauth JC, et al. Williams Obstetrics. New York: McGraw-Hill; 2001.
14. Moerman CJ, Berns MP, Bueno de Mesquita HB, Runia S. Reproductive history and cancer of the biliary tract in women. Int J Cancer 1994;57:146-53.
15. Tavani A, Negri E, La Vecchia C. Menstrual and reproductive factors and biliary tract cancers. Eur J Cancer Prev 1996;5:241-7.
16. Shukla VK, Chauhan VS, Mishra RN, Basu S. Lifestyle, reproductive factors and risk of gallbladder cancer. Singapore Med J 2008;49:912-5.
17. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659-67.
18. The Multi-Generation Regsiter. Statistics Sweden. [cited 2014 Nov 10]. Available from: http://www.scb.se/statistik/- publikationer/BE9999-2011A01-BR-BE96BR1102. pdf.
19. Description of the population in Sweden 2008. Stockholm, Sweden: Statistics Sweden; 2008.
20. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27-33.
21. Kilander C, Mattsson F, Ljung R, Lagergren J, Sadr-Azodi O. Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncol 2013:1-8.
22. Johansson L. Dodsorsaksstatistik. Historik, produktionsme-toder och tillforlitlighet. Holmqvist A. Stockholm: The Swedish National Board of Health and Welfare; 2010.
23. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
24. Evaluation of the Swedish Register of Education. Stockholm, Sweden: Statistics Sweden; 2006.
25. Marsh W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, et al. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: Diagnosis-clinical staging and pathology. J Surg Oncol 2012;106:332-8.
26. Wang MH, Shugart YY, Cole SR, Platz EA. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression. Cancer Epidemiol Biomarkers Prev 2009;18:706-11.
27. Luoto R, Kaprio J, Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 1994; 139:64-76.
28. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow SD, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-74.
29. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833-9.
30. WHO. Combined oral contraceptives and gallbladder cancer. The WHO collaborative study of neoplasia and steroid contraceptives. Int J Epidemiol 1989;18:309-14.
31. Gallus S, Negri E, Chatenoud L, Bosetti C, Franceschi S, La Vecchia C. Post-menopausal hormonal therapy and gallbladder cancer risk. Int J Cancer 2002;99:762-3.
32. Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La Vecchia C. Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies. Int J Cancer 2003;105:408-12.
33. Yearbook of Health and Medical Care. Stockholm: The National Board of Health and Welfare; 2000.
34. Schlesinger S, Aleksandrova K, Pischon T, Fedirko V, Jenab M, Trepo E, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2013;132:645-57.
35. Lambe M, Trichopoulos D, Hsieh CC, Ekbom A, Adami HO, Pavia M. Parity and cancers of the gall bladder and the extrahepatic bile ducts. Int J Cancer 1993;54:941.
36. La Vecchia C, Negri E, Franceschi S, Parazzini F. Long-term impact of reproductive factors on cancer risk. Int J Cancer 1993;53:215-9.
37. Shukla VK, Chauhan VS, Mishra RN, Basu S. Lifestyle, reproductive factors and risk of gallbladder cancer. Singapore Med J 2008;49:912-5.
38. Tavani A, Negri E, La Vecchia C. Menstrual and reproductive factors and biliary tract cancers. Eur J Cancer Prev 1996;5:241-7.
39. Plesko I, Preston-Martin S, Day NE, Tzonou A, Dimitrova E, Somogyi J. Parity and cancer risk in Slovakia. Int J Cancer 1985;36:529-33.
40. Kvale G, Heuch I, Nilssen S. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol 1994;23:691-9.
41. Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, et al. Epidemiologic aspects of gallbladder cancer: A case-control study of the SEARCH program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997;89:1132-8.
42. Andreotti G, Hou L, Gao YT, Brinton LA, Rashid A, Chen J, et al. Reproductive factors and risks of biliary tract cancers and stones: A population-based study in Shanghai, China. Br J Cancer 2010;102:1185-9.
43. Chow WH, McLaughlin JK, Menck HR, Mack TM. Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 1994; 5:267-72.
44. La Vecchia C, Negri E, D'avanzo B, Franceschi S, Boyle P. Risk factors for gallstone disease requiring surgery. Int J Epidemiol 1991;20:209-15.
45. Park SK, Andreotti G, Rashid A, Chen J, Rosenberg PS, Yu K, et al. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: A population-based study in Shanghai, China. Carcinogenesis 2010;31:842-6.
46. Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res 2012;5:41-7.
47. Sampson LK, Vickers SM, Ying W, Phillips JO. Tamoxifen- mediated growth inhibition of human cholangiocarcinoma. Cancer Res 1997;57:1743-9.